DexCom, Inc. (NASDAQ:DXCM) today announced that Steven R. Pacelli, Chief
Administrative Officer, will present an update on DexCom at the 22nd
Annual ROTH OC Growth Stock Conference in Laguna Niguel on Monday, March
15, 2010 at 8:30 a.m. (PT). The presentation, which will occur live at
the Ritz-Carlton Hotel in Laguna Niguel, will be concurrently webcast.
The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com
under the investor relations, events and webcast section, and will be
archived for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and
marketing continuous glucose monitoring systems for ambulatory use by
patients and by healthcare providers in the hospital.
Cautionary Statement Regarding Forward-Looking Statements
DexCom is a medical device company with a limited operating history.
Successful commercialization of the company’s products is subject to
numerous risks and uncertainties, including a lack of acceptance in the
marketplace by physicians and patients, the inability to manufacture
products in commercial quantities at an acceptable cost, possible delays
in the company’s development programs, the inability of patients to
receive reimbursement from third-party payors and inadequate financial
and other resources. Certain of these risks and uncertainties, in
addition to other risks, are more fully described in the company’s
annual report on Form 10-Q for the period ending September 30, 2009, as
filed with the Securities and Exchange Commission on November 4, 2009.
DexCom, Inc.
Steven R. Pacelli, Chief Administrative Officer
(858)
200-0200
